Skip to content
Disclosery

Platinum Management (NY) LLC

Follow

13F filer, CIK 1368616, NEW YORK, NY

Platinum Management (NY) LLC reported $31,122,000 across 5 holdings for the quarter ended 2015-09-30, in a 13F-HR filed 2015-11-16.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001368616-15-000006

Period
2015-09-30
Reported value
$31.1M
Holdings
5
Top 10 weight
100%
New
2
Sold out
3

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ECHO THERAPEUTICS INCnew+829,183$1.28M
NAVIDEA BIOPHARMACEUTICALS Iadded+513,997$1.17M
YOU ON DEMANDnew+3,015$6K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
ECHO THERAPEUTICS INCexited-831,883-$1.41M
VIRCexited-43,799-$125K
DLHCexited-21,977-$57K
INSPIREMD INCreduced-18,761-$29.7K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2015

Share positions as resolved from 13F-HR 0001368616-15-000006, largest first. % of portfolio is the value over $31,122,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
NAVIDEA BIOPHARMACEUTICALS INAVIDEA BIOPHARMACEUTICALS IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: 14,915,631 shares; 2014Q3: 15,046,431 shares; 2014Q4: 14,603,603 shares; 2015Q1: 11,454,831 shares; 2015Q2: 12,192,327 shares; 2015Q3: 12,706,324 shares 12,706,324$29M93.09%+513,997
ECHO THERAPEUTICS INCECHO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: 2,228,221 shares; 2014Q3: 2,283,876 shares; 2014Q4: not reported; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: 829,183 shares 829,183$1.28M4.13%new
PEDEVCO CORPPEDEVCO CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: 34,444 shares; 2014Q3: not reported; 2014Q4: not reported; 2015Q1: 34,444 shares; 2015Q2: 3,409,444 shares; 2015Q3: 3,409,444 shares 3,409,444$852K2.74%0
INSPIREMD INCINSPIREMD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: not reported; 2014Q3: 24,453 shares; 2014Q4: not reported; 2015Q1: 24,453 shares; 2015Q2: 24,453 shares; 2015Q3: 5,692 shares 5,692$9K0.03%-18,761
YOU ON DEMANDYOU ON DEMANDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: not reported; 2014Q3: not reported; 2014Q4: not reported; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: 3,015 shares 3,015$6K0.02%newThe CUSIP as filed is malformed.

Sold out in Q3 2015

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
ECHO THERAPEUTICS INCECHO THERAPEUTICS INC831,883$1.41Mshares
VIRCVIRCO MFG CO43,799$125Kshares
DLHCDLH HLDGS CORP21,977$57Kshares

How Q3 2015 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001368616-15-000006 base2015-11-16acceptance time not in the bulk data set